Trade BIO stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Bio-Rad Laboratories, Inc.Class A (BIO) is trading at US$376.41, down 1.57% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$10.16B. Over the past 52 weeks, BIO has traded between US$236.73 and US$396.23. On Syfe you can trade BIO with $0 commission and add it to your watchlist.
| Previous close | US$382.41 |
|---|---|
| Market cap | US$10.16B |
| P/E ratio | 37.08 |
| 52-week range | US$236.73 – US$396.23 |
| Volume | 323.48K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Bio-Rad Laboratories, Inc.Class A
Bio-Rad Laboratories, Inc. engages in the development, manufacturing, and marketing of a portfolio of instruments, systems, reagents, and consumables. It operates through the following segments: Life Science and Clinical Diagnostics. The Life Science segment includes development, manufacturing, and marketing of instruments, systems, reagents, and consumables used to separate, purify, characterize, and quantify biological materials. The Clinical Diagnostics segment focuses on designing, manufacturing, marketing, and support of diagnostic test systems, informatics solutions, test kits, and specialized quality controls for clinical laboratories in the global diagnostics market. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.
Year: 1980
RBC Adjusts PT on Bio-Rad Laboratories to $390 From $370, Maintains Outperform Rating
Aug 7, 12:12 PM · MT Newswires
RBC Adjusts Price Target on Bio-Rad Laboratories to $370 From $320, Maintains Outperform Rating
Aug 5, 12:06 PM · MT Newswires
Bio-Rad Laboratories Q2 Adjusted Earnings Rise, Revenue Falls
Aug 4, 8:55 PM · MT Newswires
-- Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Reports Q2 Revenue $651.0M, vs. FactSet Est of $624.0M
Aug 4, 8:24 PM · MT Newswires
-- Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Posts Q2 Adjusted EPS $2.62 per Share, vs. FactSet Est of $1.75
Aug 4, 8:19 PM · MT Newswires
Bio-Rad Laboratories, Inc.Class A (BIO) stock is trading at US$376.41, -1.57% from the previous close of US$382.41.
The market cap for Bio-Rad Laboratories, Inc.Class A (BIO) stock is approximately US$10.16B.
The price-to-earnings ratio for Bio-Rad Laboratories, Inc.Class A (BIO) is 37.08, based on the latest reported earnings.
The 52-week high for Bio-Rad Laboratories, Inc.Class A (BIO) stock is US$396.23.
The 52-week low for Bio-Rad Laboratories, Inc.Class A (BIO) stock is US$236.73.
Bio-Rad Laboratories, Inc.Class A (BIO) does not currently pay a dividend.
Stay on top of BIO
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
